TherapeuticsMD Inc. (NASDAQ: TXMD)
$1.0800
-0.0300 ( -0.92% ) 22.7K
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Market Data
Open
$1.0800
Previous close
$1.1100
Volume
22.7K
Market cap
$12.34M
Day range
$1.0650 - $1.1600
52 week range
$0.7000 - $2.7500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 65 | May 10, 2024 |
8-k | 8K-related | 16 | May 10, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
10-k | Annual reports | 89 | Mar 29, 2024 |
8-k | 8K-related | 15 | Mar 29, 2024 |